Nuvve Holding Corp SEC Filings

Nuvve Holding Corp. filed a revised proxy amending a scrivener's error to show 19,942,839 shares outstanding (previously 20,252,314) and seeks shareholder approval for a Reverse Stock Split with a board-determined ratio in the range of 1-for-2 to 1-for-40. The company states the reverse split is intended to satisfy Nasdaq minimum bid price requirements and notes an active appeal of a Nasdaq delisting determination. Implementation must be completed no later than 10 business days before a date set by the Nasdaq Hearing Panel if the split is approved. The proxy discloses solicitation arrangements, including an estimated fee to Campaign Management of up to $10,000, event logistics for a Special Meeting and adjusted share-and-capital mechanics and tax and fractional-share treatments in the event of the reverse split.

Gregory Poilasne, Chief Executive Officer and Director of Nuvve Holding Corp. (NVVE), reported an open-market sale of common stock on 08/22/2025. The Form 4 shows 200,000 shares were disposed of at a volume-weighted average price of $0.4725 per share, with the reported intraday price range $0.47 to $0.48. After the sale the filing lists 333,474.784 shares beneficially owned by the reporting person in a direct capacity. The sale was signed and dated by Mr. Poilasne on 08/26/2025. The filer notes the issuer can provide detailed per-transaction share counts on request.

James Andrew Altucher, a director of Nuvve Holding Corp. (NVVE), acquired 100,000 shares of the issuer's common stock on 08/24/2025. The shares were issued as restricted stock units (RSUs) under the company's Amended and Restated 2020 Long-Term Incentive Plan, each RSU representing the right to one share. The RSUs vested immediately and were reported with a $0 per-share price on Form 4, resulting in 100,000 shares beneficially owned following the transaction. The filing is signed and dated 08/26/2025.

Nuvve Holding Corp. insider Brian Arthur Johnson received 100,000 restricted stock units (RSUs) that vested immediately, each representing one share of common stock. The award was recorded as a non‑derivative acquisition on 08/24/2025 at a reported price of $0, leaving Mr. Johnson with 100,000 shares beneficially owned following the transaction. The filing identifies Mr. Johnson as a director and shows the Form 4 was signed on 08/26/2025.

This disclosure states the RSUs were granted under the company’s Amended and Restated 2020 Long‑Term Incentive Plan and that each RSU converts to one share on vesting. No other transactions, option grants, sales, or additional material terms (such as service conditions or forfeiture provisions) are stated in the form.